YL202/BNT326, a HER3-targeted ADC, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Breast Cancer: Preliminary Results from a First-in-human Phase I Trial.

Ying Cheng, Xiaochen Zhang,Jian Liu,Zhangzhou Huang, Dongqing Lv,Yiping Zhang,Xiaojia Wang,Arvind Chaudhry,Harshad Amin, Senthil Damodaran, Shiven B. Patel, Hadeel Assad,Arielle Shebay Lee, Hui Zhao, Jinyun Bai, Tongtong Xue, Steve Chin

Journal of Clinical Oncology（2024）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined